Fracture risk after radium-223 (Ra-223) in metastatic castration resistant prostate cancer (mCRPC).
暂无分享,去创建一个
C. Parker | A. Padhani | D. Koh | N. Tunariu | E. Hall | M. Blackledge | R. Alonzi | A. Tree | H. Tovey | J. Staffurth | H. Stidwill | J. Finch | P. Chatfield | S. Perry